Part,  Chapter, Paragraph

  1   II,     5.  3.  2|         from 34 European countries regarding teaching and continuing
  2   II,     5.  3.  2|      survey/~ ~A global comparison regarding patient access to cancer
  3   II,     5.  3.  7|      entitled “A global comparison regarding patient access to cancer
  4   II,     5.  3.  7|          highlights the inequities regarding the ability of patients
  5   II,     5.  3.  7|        Technology Assessment (HTA) regarding a new cancer drug is done
  6   II,     5.  3.  8|      information on best practices regarding diagnosis, treatment, rehabilitation
  7   II,     5.  5.Int|           patientsneeds in areas regarding the development of policies
  8   II,     5.  5.  2|           huge information deficit regarding Alzheimer’s disease;~· As
  9   II,     5.  5.  3|          are partly very different regarding the sampling design and
 10   II,     5.  5.  3|           to regularly update data regarding eating disorders. Routinely
 11   II,     5.  5.  3|           decisions and strategies regarding mental health policy.~Mortality~
 12   II,     5.  5.  3|        from Sweden were available. Regarding the prescription of atypical
 13   II,     5.  5.  3|          Europe. In contrast, data regarding the mortality in patients
 14   II,     5.  5.  3|            and practice parameters regarding the management of epilepsy
 15   II,     5.  5.  3| legislations of the EU governments regarding employment and driving in
 16   II,     5.  5.  3|            those diagnosed with MS regarding the Directive, its scope
 17   II,     5.  5.  3|      health technology assessments regarding the management of PD have
 18   II,     5.  7.  5|            CKD diagnosis. Policies regarding evaluation of care including
 19   II,     5.  7.  6|           national health policies regarding RRT for ESRD. In contrast,
 20   II,     5.  8.  3|            there are some problems regarding the accuracy of COPD mortality
 21   II,     5.  9. FB|          the two groups were found regarding the incidence of atopy and
 22   II,     5.  9.  6|            among existing programs regarding chronic respiratory diseases.
 23   II,     5. 10.  4|            of health professionals regarding the disease. On the other
 24   II,     5. 10.  5|       allergy and food intolerance regarding the labelling of substances
 25   II,     5. 11.  3|      industry, in particular those regarding toxicity requirements and
 26   II,     5. 11.  3|        receive good medical advice regarding the most appropriate treatment
 27   II,     5. 11.  3|            collected and available regarding NMSC in Europe. In Trentino,
 28   II,     5. 14.  3|        limitation has implications regarding the use of oral disadvantage
 29   II,     5. 15.  3|         published report available regarding the contribution of RD to
 30   II,     5. 15.  4|            been recently published regarding the experience acquired
 31   II,     7.  4    |        human suffering;~· Evidence regarding the effectiveness of interventions
 32   II,     7.  4.  1|              Safety of adolescents~Regarding adolescents and young adults: ,
 33   II,     7.  4.  1|        European situation analysis regarding injuries and risk taking,
 34   II,     7.  5    |        recommends specific actions regarding surveillance, national action
 35   II,     7.  5    |         2007).~ ~Also policy tools regardingnational action plans”
 36   II,     8.  1.  2|      disability, work limitations (regarding the kind of work or the
 37   II,     8.  1.  2|            relates to restrictions regarding activities in general. EU-SILC
 38   II,     8.  1.  4|          Public Health statistics) regarding the full implementation
 39   II,     8.  1.  5|       October 2003 a Communication regarding the policy follow up to
 40   II,     8.  2.  1|          and stereotypical beliefs regarding people with intellectual
 41   II,     9        |          determine numbers. Trends regarding alcohol drinking among young
 42   II,     9        |       alcohol itself, expectancies regarding its effects, and social
 43   II,     9        |          effects, and social norms regarding drunken comportment. Societies
 44   II,     9.  1.  1|      health.~ ~Further information regarding reproduction issues is presented
 45   II,     9.  1.  2|         terms of preventive action regarding environmental risk factors,
 46   II,     9.  1.  2|          disease) and e) practices regarding registration of a baby as
 47   II,     9.  1.  2|       different laws and practices regarding the recording of late terminations.
 48   II,     9.  1.  2| differences in policy and practice regarding prenatal screening and TOPFA,
 49   II,     9.  1.  2|    prevalence estimate unless data regarding surgery in the first three
 50   II,     9.  1.  2|          determine numbers. Trends regarding alcohol drinking among young
 51   II,     9.  1.  2|          of the European directive regarding patient consent. Although
 52   II,     9.  2.  2|            Countries was data-rich regarding that child health inequalities
 53   II,     9.  2.  4|       alcohol itself, expectancies regarding its effects, and social
 54   II,     9.  2.  4|          effects, and social norms regarding drunken comportment. Societies
 55   II,     9.  3.  1|           the stigmatising thought regarding ED originates (Shah 2002).
 56   II,     9.  4.  5|        quality of service delivery regarding both health and long-term
 57   II,     9.  4.  5|            fostering the emergency regarding innovative, ICT-based products,
 58   II,     9.  5.  3|        about alcohol, expectancies regarding the effects of alcohol and
 59   II,     9.  5.  3|           alcohol and social norms regarding drunken comportment. This
 60   II,     9.  5.  5|          research material notably regarding the impact of men and boys’
 61  III,    10.  2.  1|   understanding of the main trends regarding drug use and drug-related
 62  III,    10.  2.  1|      helping problem drug users or regarding the accessibility of treatments
 63  III,    10.  2.  1|      findings over the past decade regarding physical activity as an
 64  III,    10.  2.  1|       response to current concerns regarding physical activity levels.~ ~
 65  III,    10.  2.  1|          when they were comparable regarding data collection methodology
 66  III,    10.  2.  1|            piece of EU legislation regarding the labelling of foodstuffs.
 67  III,    10.  2.  4|            trends” can be observed regarding the understanding of diseases,
 68  III,    10.  3.  1|        conducted over recent years regarding possible health effects
 69  III,    10.  3.  2|           conclusions can be drawn regarding their effects on humans.~ ~
 70  III,    10.  3.  2|           most sensitive parameter regarding human toxicity is the adverse
 71  III,    10.  4.  1|      setting the level of ambition regarding air quality in the EU up
 72  III,    10.  4.  2|           most sensitive parameter regarding human toxicity is the adverse
 73  III,    10.  4.  2|          the EEC Treaty in matters regarding food) establishes that,
 74  III,    10.  4.  2|        relate to the uncertainties regarding the interpretation of the
 75  III,    10.  4.  2|           associated complications regarding the tasks EFSA has relating
 76  III,    10.  4.  2|        opinions, on generic issues regarding pesticide risk assessment
 77  III,    10.  4.  2|          been defined and may vary regarding compound and type of exposure (
 78  III,    10.  4.  2|      mandate is risk communication regarding risks associated with the
 79  III,    10.  5.  3|            and safety requirements regarding the exposure of workers
 80   IV,    11.  1.  5|         are some important lessons regarding financial incentives that
 81   IV,    11.  1.  5|          general, and specifically regarding preventive health and lifestyles.
 82   IV,    11.  3.  2|        payer, and policy decisions regarding cost-sharing arrangements.
 83   IV,    11.  5.  6|          European common standards regarding legal, ethical, protection
 84   IV,    11.  6.  4|         pharmaceuticals. Decisions regarding benefit catalogues can only
 85   IV,    11.  6.  4|          the one hand, information regarding the cost-effectiveness of
 86   IV,    11.  6.  4|             websites and materials regarding validated indicators, nine
 87   IV,    12.  5    |           to Community initiatives regarding registries on cancer, based,
 88   IV,    12. 10    |         young people aged 15 to 19 regarding Clamydia. Website: www k
 89   IV,    12. 10    |       protection of the population regarding environmental health hazards
 90   IV,    12. 10    |           comply to high standards regarding biological and chemical
 91   IV,    12. 10    |           of drug use~particularly regarding polydrug usage~(including
 92   IV,    12. 10    |          waste disposal~ High~o 01 regarding "Packaging and Alternative
 93   IV,    12. 10    |           high~Law on Restrictions regarding Sale, Advertising and Use
 94   IV,    12. 10    |   initiatives has been undertaking regarding healthy nutrition, tobacco
 95   IV,    12. 10    |          Decisions 346-352/03/2007 regarding the list of localities within
 96   IV,    12. 10    |           water~ High~Law 458/2002 regarding drinking water modified
 97   IV,    12. 10    |         disposal~ High~GD 195/2005 regarding the environment protection~
 98   IV,    12. 10    |           Noise: public health law regarding occupational health~Human
 99   IV,    12. 10    |       communicate with the Riksdag regarding public health issues.~ ~
100   IV,    12. 10    |           last 5 years regulations regarding environment have been harmonised